Ovagen International Ltd.
Beer & Burgess
The project involved the construction of a new industrial facility for Ovagen Limited, a biotechnology company that has developed a process of producing germ-free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry.
Ovagen uses sterile manufacturing technologies as developed in the pharmaceutical industry in conjunction with biosafety decontamination techniques and best-practice poultry husbandry methods. The GF eggs are used for the manufacture of vaccines and therapeutic proteins for anti-cancer therapies.
This project consisted of a 2,500m² building which contains Germ-Free Suites for flocks of 550 birds, Isolators, Incubators Laboratories, Egg Processing Units, Research & Development Units, Head Office, a .5km access road and associated works. The project was delivered against a very tight schedule.
The project involved;
Please wait while you are redirected to the right page...